ASCO 2026 Poster Session Research
At the 2026 American Society of Clinical Oncology Annual Meeting poster session, we asked four scientists to discuss their research.
Listen to the episode to hear:
Peter Stanfield, of the University of Wisconsin, explains his research on cancer screening rates in transgender and gender-diverse people.
Nico Gotera, of the University of Texas Health Science Center, explains research on GLP-1 medicines and rates of breast cancer in postmenopausal women.
Anna Tanasijevic, of the Dana-Farber Cancer Institute, explains research on how much cancer survivors exercise.
Xianghui Zou, of NYU Langone Health, explains research on the timing of immunotherapy infusions for people with early-stage triple-negative breast cancer.
Peter Stanfield is a second-year medical student who's passionate about cancer care, with a special interest in advancing equitable care for LGBTQ+ patients and eliminating healthcare disparities.
Nico Gotera, DO, MPH, is a clinical assistant professor at UT Health San Antonio.
Anna Tanasijevic, MPH, is the associate director of research operations for Dana-Farber's Zakim Center for Integrative Therapies and Healthy Living.
Xianghui Zou, MD, MPH, is a Hematology and Medical Oncology Fellow at the NYU Grossman Long Island School of Medicine.
Your donation goes directly to what you read, hear, and see on Breastcancer.org.